Kapa Biosystems to be Acquired by Roche Holding

Roche Holding (OTCMKTS:RHHBY) announced that it will buy U.S. based gene-technology company Kapa Biosystems.
According to Market Watch:

Basel-based Roche said it will buy Kapa Biosystems Inc., based in Wilmington, Mass., for an undisclosed sum. The closely held U.S. company has been working on ways to accelerate research into genomes, the complete set of DNA with within a single cell.
Roche is interested in the area because it leads to a better understanding of the genetic roots of diseases by identifying genetic mutations. Genome research can affect the future ability to diagnose, monitor and treat cancer and other conditions.
Kapa’s protein-engineering technology allows for the generation and screening of large numbers of enzyme variants, Roche said. Tailored enzymes with improved performance for specific applications can be rapidly selected, speeding up product development time lines, the company added.

Click here to read the full article on Market Watch.